An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Omnicell, a provider of medication management solutions, will release its first quarter 2023 financial results on May 2, 2023, after market close.
The company will host a conference call at 4:30 p.m. ET that same day to discuss these results. Interested parties can participate via phone or access a link to the live and archived webcast on the company's Investor Relations page.
Since 1992, Omnicell has focused on transforming pharmacy care delivery, aiming to improve outcomes and reduce costs through advanced automation and analytics. Its services support healthcare facilities in managing medications efficiently, enhancing patient safety, and reducing hospital readmissions.
Positive
None.
Negative
None.
FORT WORTH, Texas--(BUSINESS WIRE)--
Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for healthcare systems and pharmacies, will release its financial results for the first quarter 2023 after market close on Tuesday, May 2, 2023. The Company will host a conference call and webcast to discuss its financial results at 4:30 p.m. ET that same day.
All interested parties are invited to listen to the live call and presentation by dialing (888) 550-5424 in the U.S. or (646) 960-0819 in international locations. A link to the live and archived webcast will also be available on the Investor Relations section of Omnicell’s website at https://ir.omnicell.com/events-and-presentations/.
About Omnicell
Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model to dramatically improve outcomes and lower costs. Through the vision of the autonomous pharmacy, a combination of automation, intelligence, and technology-enabled services, powered by a cloud data platform, Omnicell supports more efficient ways to manage medications across all care settings. Healthcare facilities worldwide use Omnicell automation and analytics solutions to help increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety. Institutional and retail pharmacies across North America and the United Kingdom leverage Omnicell's innovative medication adherence and population health solutions to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions. To learn more, visit www.omnicell.com.
OMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.
Omnicell will report its Q1 2023 earnings on May 2, 2023, after market close.
What time is the Omnicell Q1 2023 earnings call?
The earnings call for Q1 2023 will take place at 4:30 p.m. ET on May 2, 2023.
How can I access the Omnicell earnings call?
You can access the Omnicell earnings call by dialing (888) 550-5424 in the U.S. or (646) 960-0819 internationally. A webcast will also be available on their Investor Relations website.
What is Omnicell's focus in the healthcare sector?
Omnicell focuses on transforming pharmacy care delivery through automation and analytics to improve patient outcomes and reduce costs.
